ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 80 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,755,000 | +12.5% | 93,781 | +28.1% | 0.01% | +25.0% |
| Q4 2015 | $2,449,000 | -12.8% | 73,229 | -5.7% | 0.00% | -20.0% |
| Q3 2015 | $2,807,000 | -10.3% | 77,653 | +11.6% | 0.01% | 0.0% |
| Q2 2015 | $3,130,000 | +781.7% | 69,565 | +500.4% | 0.01% | +400.0% |
| Q1 2015 | $355,000 | -86.4% | 11,586 | -77.3% | 0.00% | -80.0% |
| Q4 2014 | $2,612,000 | +45.3% | 51,099 | +12.5% | 0.01% | +66.7% |
| Q3 2014 | $1,798,000 | +1.6% | 45,437 | -3.4% | 0.00% | 0.0% |
| Q2 2014 | $1,770,000 | +11.0% | 47,033 | +10.4% | 0.00% | 0.0% |
| Q1 2014 | $1,594,000 | +8.4% | 42,606 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $1,471,000 | – | 40,146 | +200630.0% | 0.00% | – |
| Q3 2013 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |